K
Kolb Hj
Researcher at Ludwig Maximilian University of Munich
Publications - 110
Citations - 4795
Kolb Hj is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Transplantation & Bone marrow. The author has an hindex of 34, co-authored 110 publications receiving 4604 citations.
Papers
More filters
Journal ArticleDOI
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
Alois Gratwohl,Jo Hermans,JohnM. Goldman,William Arcese,Enric Carreras,Agnès Devergie,Francesco Frassoni,G. Gahrton,Kolb Hj,Dietger Niederwieser,Tapani Ruutu,J P Vernant,T. de Witte,Jane F. Apperley +13 more
TL;DR: In this paper, a simple system based on five main factors gives adequate risk assessment for counselling of patients and taking decisions, which is highly predictive for leukaemia-free survival, survival and transplant-related mortality.
Journal ArticleDOI
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey
Nina Salooja,Richard Szydlo,Gérard Socié,B Rio,Ratna Chatterjee,Per Ljungman,M. T. Van Lint,R. L. Powles,Graham Jackson,M Hinterberger-Fischer,Kolb Hj,Jane F. Apperley +11 more
TL;DR: Pregnancy after SCT is likely to have a successful outcome, and pregnancies in allograft patients who have received total body irradiation should be treated as high risk for maternal and fetal complications.
Journal ArticleDOI
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)
Ernst Holler,Kolb Hj,J. Mittermüller,M. Kaul,Georg Ledderose,T Duell,B Seeber,Michael Schleuning,R. Hintermeier-Knabe,B. Ertl +9 more
TL;DR: Application of monoclonal anti-TNF alpha in low and intermediate doses was safe and not associated with an increased incidence of infectious or hematologic complications and support further investigation of this novel approach in randomized trials.
Journal ArticleDOI
Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation
Kolb Hj,Gérard Socié,Thomas Duell,Maria Theresa Van Lint,André Tichelli,Jane F. Apperley,Elke Nekolla,Per Ljungman,Niels Jacobsen,M. van Weel,Roland R. Wick,Melanie Weiss,H. Grant Prentice +12 more
TL;DR: The aim of this study was to assess the risk for malignant neoplasm in long-term survivors of marrow transplantation and to identify risk factors for new malignant disease.
Journal ArticleDOI
Health and Functional Status of Long-Term Survivors of Bone Marrow Transplantation
T Duell,M. T. Van Lint,Per Ljungman,André Tichelli,Gérard Socié,J. F. Apperley,M. Weiss,A Cohen,Elke Nekolla,Kolb Hj +9 more
TL;DR: A retrospective, descriptive study on late death, health, and social reintegration of patients who had received allogeneic and syngeneic bone marrow transplants for hematologic disorders before 31 December 1985 and who had survived for at least 5 years after receiving the graft.